Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $37.2000 (0.27%) ($37.1000 - $37.2000) on Wed. Jul. 12, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 54 | Latest Price | $37.2000(0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Weekly Trend | HALO advances 2.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) BNDX(32%) XBI(31%) BLOK(30%) IBB(29%) IGOV(27%) | Factors Impacting HALO price | HALO will decline at least -1.31% in a week (0% probabilities). INDA(-22%) TBT(-20%) UUP(-14%) XLRE(-8%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $36.98(0.59%) | 10 Day Moving Average | $36.39(2.23%) | 20 Day Moving Average | $35.56(4.61%) | To recent high | -0.2% | To recent low | 23.4% | Market Cap | $5.084b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |